CLINICAL UPDATES Non-Hodgkin lymphoma

被引：82
作者：
Al-Naeeb, Anna Bowzyk [1 ]
Ajithkumar, Thankamma [2 ]
Behan, Sarah [3 ]
Hodson, Daniel James [3 ,4 ]
机构：
[1] Bedford Hosp, Dept Oncol, Bedford, England
[2] Cambridge Univ Hosp NHS Trust, Dept Oncol, Cambridge, England
[3] Cambridge Univ Hosp NHS Trust, Dept Haematol, Cambridge, England
[4] Univ Cambridge, Wellcome Trust, Med Res Council, Stem Cell Inst, Cambridge, England
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2018年 / 362卷
关键词：
B-CELL LYMPHOMA; CHEMOTHERAPY PLUS RITUXIMAB; RANDOMIZED CONTROLLED-TRIAL; MALIGNANCY RESEARCH NETWORK; FOLLICULAR LYMPHOMA; ADVANCED-STAGE; OPEN-LABEL; HEMATOLOGICAL MALIGNANCY; 1ST-LINE TREATMENT; HIGH-RISK;
D O I：
10.1136/bmj.k3204
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：7
相关论文
共 34 条
  • [1] Anticancer chemotherapy in teenagers and young adults: managing long term side effects
    Ahmad, Saif S.
    Reinius, Marika A. V.
    Hatcher, Helen M.
    Ajithkumar, Thankamma V.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2016, 354 : i4567
  • [2] Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma
    Al-Tourah, Abdulwahab J.
    Gill, Karamjit K.
    Chhanabhai, Mukesh
    Hoskins, Paul J.
    Klasa, Richard J.
    Savage, Kerry J.
    Sehn, Laurie H.
    Shenkier, Tamara N.
    Gascoyne, Randy D.
    Connors, Joseph M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (32) : 5165 - 5169
  • [3] [Anonymous], GLOBOCAN 2012 EST CA
  • [4] Rituximab versus a watch-and-wait approach in patients with advanced- stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial
    Ardeshna, Kirit M.
    Qian, Wendi
    Smith, Paul
    Braganca, Nivette
    Lowry, Lisa
    Patrick, Pip
    Warden, June
    Stevens, Lindsey
    Pocock, Christopher F. E.
    Miall, Fiona
    Cunningham, David
    Davies, John
    Jack, Andrew
    Stephens, Richard
    Walewski, Jan
    Ferhanoglu, Burhan
    Bradstock, Ken
    Linch, David C.
    [J]. LANCET ONCOLOGY, 2014, 15 (04) : 424 - 435
  • [5] Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial
    Ardeshna, KM
    Smith, P
    Norton, A
    Hancock, BW
    Hoskin, PJ
    MacLennan, KA
    Marcus, RE
    Jelliffe, A
    Hudson, GV
    Linch, DC
    [J]. LANCET, 2003, 362 (9383) : 516 - 522
  • [6] B-cell receptor pathway modulators in NHL
    Blum, Kristie A.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 82 - 91
  • [7] Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: A randomized study from the Groupe D'Etude des Lymphomes Folliculaires
    Brice, P
    Bastion, Y
    Lepage, E
    Brousse, N
    Haioun, C
    Moreau, P
    Straetmans, N
    Tilly, H
    Tabah, I
    SolalCeligny, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1110 - 1117
  • [8] The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015
    Brown, Katrina F.
    Rumgay, Harriet
    Dunlop, Casey
    Ryan, Margaret
    Quartly, Frances
    Cox, Alison
    Deas, Andrew
    Elliss-Brookes, Lucy
    Gavin, Anna
    Hounsome, Luke
    Huws, Dyfed
    Ormiston-Smith, Nick
    Shelton, Jon
    White, Ceri
    Parkin, D. Max
    [J]. BRITISH JOURNAL OF CANCER, 2018, 118 (08) : 1130 - 1141
  • [9] Cancer Research UK (CRUK), NONH LYMPH STAT
  • [10] Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
    Casulo, Carla
    Byrtek, Michelle
    Dawson, Keith L.
    Zhou, Xiaolei
    Farber, Charles M.
    Flowers, Christopher R.
    Hainsworth, John D.
    Maurer, Matthew J.
    Cerhan, James R.
    Link, Brian K.
    Zelenetz, Andrew D.
    Friedberg, Jonathan W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (23) : 2516 - U55
1234